Impact of the Definition Utilized on the Rate of Contrast-Induced Nephropathy in Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 103, Issue 12, 2009, Pages 1657-1662

  Jabara, Refat ^a   Gadesam, Radhika R ^a   Pendyala, Lakshmana K ^a   Knopf, William D ^a   Chronos, Nicolas ^a   Chen, Jack P ^a   Viel, Kevin ^b   King III, Spencer B ^a   Manoukian, Steven V ^c  

^a Saint Joseph's Hospital of Atlanta   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SARAH CANNON RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; CREATININE; HEPARIN; HIRULOG; IOXILAN;

ACUTE HEART INFARCTION; ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC PATIENT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OSMOLARITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; REOPERATION; ST SEGMENT ELEVATION; STROKE; VISCOSITY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IOHEXOL; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 67649415028     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.02.039     Document Type: Article

References (18)

1. McIntosh C.L., and Reed R. Ioxilan injection. An overview and results of aortofemoral arteriography study. Invest Radiol 29 suppl (1994) S40-S42
2. Roth R., Akin M., Deligonul U., and Kern M.J. Influence of radiographic contrast media viscosity to flow through coronary angiographic catheters. Cathet Cardiovasc Diagn 22 (1991) 290-294
3. Johnson C., Levey A.S., Coresh J., Levin A., Lau J., and Eknoyan G. Clinical practice guidelines for chronic kidney disease in adults: part II: glomerular filtration rate, proteinuria, and other markers. Am Fam Phys 70 (2004) 1091-1097
4. World Health Organization. Nutritional Anemias: Report of a WHO Scientific Group. WHO Technical Report Series 405 (1968), World Health Organization, Geneva, Switzerland 1-37
5. Rihal C.S., Textor S.C., Grill D.E., Berger P.B., Ting H.H., Best P.J., Singh M., Bell M.R., Barsness G.W., Mathew V., Garratt K.N., and Holmes Jr. D.R. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
6. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
7. Harjai K.J., Raizada A., Shenoy C., Sattur S., Orshaw P., Yaeger K., Boura J., Aboufares A., Sporn D., and Stapleton D. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol 101 (2008) 812-819
8. Barrett B.J., and Parfrey P.S. Preventing nephropathy induced by contrast medium. N Engl J Med 354 (2006) 379-386
9. Mehran R. ICON-a prospective, randomized, placebo-controlled trial of ioxaglate vs. iodixanol in patients at increased risk for contrast nephropathy. Presented at Transcatheter Cardiovascular Therapeutics; October 25, 2006; Washington, DC.
10. Solomon R.J., Natarajan M.K., Doucet S., Sharma S.K., Staniloae C.S., Katholi R.E., Gelormini J.L., Labinaz M., Moreyra A.E., and Investigators of the CARE Study. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 115 (2007) 3189-3196
11. Voeltz M.D., Nelson M.A., McDaniel M.C., and Manoukian S.V. The important properties of contrast media: focus on viscosity. J Invasive Cardiol 19 suppl (2007) 1A-9A
12. Weisbord S.D., Hartwig K.C., Sonel A.F., Fine M.J., and Palevsky P. The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography. Catheter Cardiovasc Interv 71 (2008) 879-885
13. Nicot G.S., Merle L.J., Charmes J.P., Valette J.P., Nouaille Y.D., Lachâtre G.F., and Leroux-Robert C. Transient glomerular proteinuria, enzymuria, and nephrotoxic reaction induced by radiocontrast media. JAMA 252 (1984) 2432-2434
14. Rickli H., Benou K., Ammann P., Fehr T., Brunner-La Rocca H.P., Petridis H., Riesen W., and Wüthrich R.P. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol 61 (2004) 98-102
15. Bachorzewska-Gajewska H., Malyszko J., Sitniewska E., Malyszko J.S., and Dobrzycki S. Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 26 (2006) 287-292
16. Porter G.A. Contrast-associated nephropathy. Am J Cardiol 64 suppl (1989) 22E-26E
17. Guitterez N.V., Diaz A., Timmis G.C., et al. Determinants of serum creatinine trajectory in acute contrast nephropathy. J Interv Cardiol 15 (2002) 349-354
18. Morcos S.K. Contrast media-induced nephrotoxicity-questions and answers. Br J Radiol 71 (1998) 357-365